For example, whether the impact of ATX on the immune contexture of lung cancer would differ from its impact on pancreatic cancer lung metastases remains in question and may hold relevance for the potential development of combination therapies targeting ATX to foster efficacy of immunotherapies. This evidence concerns the gene ENPP2 and lung carcinoma.